Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Best Dividend Aristocrats For October 2025

01:00am, Sunday, 28'th Sep 2025
Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date, with notable dispersion among individual stock returns. Dividend growth remains robust, with 55 of 69 Aristoc
ABT gains momentum with strong FreeStyle Libre sales and Diagnostics growth but global macro headwinds weigh on performance.
In the closing of the recent trading day, Abbott (ABT) stood at $133.89, denoting a -1.47% move from the preceding trading day.
ABBOTT PARK, Ill., Sept. 24, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens.
President Donald Trump's trade policies have introduced plenty of volatility to the stock market this year. Steeper tariffs could impact consumer spending and the broader economy in ways that could ha

1 Dividend King To Hold And 2 Worth Buying Now

12:37pm, Friday, 19'th Sep 2025
It's often said that cash is king, but I would take it one step further. Abbott Laboratories is an AA-rated Dividend King with healthy growth prospects but a rich valuation. I'm waiting for a pullback
ABBOTT PARK, Ill., Sept. 19, 2025 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.
Forget the dividend darlings everyone already owns -- the real money in income investing comes from companies raising their payouts faster than inflation while keeping enough cash to reinvest in growt
ABT's strong Nutrition, Diabetes Care and EPD growth fuel momentum, but macro and currency headwinds challenge its outlook.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

3 No-Brainer Dividend Stocks to Buy in September

06:42am, Saturday, 13'th Sep 2025
Some decisions are tough to make. Others are so easy that they don't require much thought and are practically no-brainers.
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two stocks is more attractive to value investors?
Abbott CEO highlights the company's devices that could make healthcare faster and easier.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE